These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23669565)

  • 1. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
    Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
    J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
    Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
    J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of hepatocyte cell adhesion molecule on gene expression profile of human bladder transitional cell carcinoma cell line].
    Wang QJ; Lv CK; Tao J; Du HF; Fan YR; Song XD; Luo CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):190-8. PubMed ID: 23643009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional significance of the hepaCAM gene in bladder cancer.
    He Y; Wu X; Luo C; Wang L; Lin J
    BMC Cancer; 2010 Mar; 10():83. PubMed ID: 20205955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
    Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.
    Wang X; Chen E; Tang M; Yang X; Wang Y; Quan Z; Wu X; Luo C
    Tumour Biol; 2016 Aug; 37(8):10731-43. PubMed ID: 26873485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival.
    Sanli T; Storozhuk Y; Linher-Melville K; Bristow RG; Laderout K; Viollet B; Wright J; Singh G; Tsakiridis T
    Radiother Oncol; 2012 Mar; 102(3):459-65. PubMed ID: 22225791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma.
    Zhang QL; Luo CL; Wu XH; Wang CY; Xu X; Zhang YY; Liu Q; Shen SL
    J Cell Biochem; 2011 Oct; 112(10):2910-9. PubMed ID: 21618595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.
    Li F; Zeng J; Gao Y; Guan Z; Ma Z; Shi Q; Du C; Jia J; Xu S; Wang X; Chang L; He D; Guo P
    PLoS One; 2015; 10(9):e0138390. PubMed ID: 26397365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1285 Regulates 17β-Estradiol-Inhibited Immature Boar Sertoli Cell Proliferation via Adenosine Monophosphate-Activated Protein Kinase Activation.
    Jiao ZJ; Yi W; Rong YW; Kee JD; Zhong WX
    Endocrinology; 2015 Nov; 156(11):4059-70. PubMed ID: 26287402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.
    Pan C; Wu X; Luo C; Yang S; Pu J; Wang C; Shen S
    Urol Int; 2010; 85(3):347-54. PubMed ID: 20628239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.
    Sun CH; Chang YH; Pan CC
    Histopathology; 2011 Jun; 58(7):1054-63. PubMed ID: 21707707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
    Aranha O; Wood DP; Sarkar FH
    Clin Cancer Res; 2000 Mar; 6(3):891-900. PubMed ID: 10741713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
    Nishikawa M; Miyake H; Behnsawy HM; Fujisawa M
    Urol Oncol; 2015 Apr; 33(4):166.e9-15. PubMed ID: 25618298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivo.
    Du HF; Ou LP; Lv CK; Yang X; Song XD; Fan YR; Wu XH; Luo CL
    Cancer Biol Ther; 2015; 16(10):1502-13. PubMed ID: 26192362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
    Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
    Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.